Gen-Probe Logs Record Clinical Dx Sales, Weaker Blood Screening Revenues in Q4 2010

The company also updated investors on the uptake of its recently launched Panther molecular diagnostics platform in Europe, and on plans for US commercialization and test menu build-out for the instrument.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.